Sara L Van Driest1,2, Matthew D Marshall3, Brian Hachey4, Cole Beck5, Kim Crum1, Jill Owen1, Andrew H Smith1, Prince J Kannankeril1, Alison Woodworth6, Richard M Caprioli4, Leena Choi5. 1. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 3. Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. 6. Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.
Abstract
AIMS: One barrier contributing to the lack of pharmacokinetic (PK) data in paediatric populations is the need for serial sampling. Analysis of clinically obtained specimens and data may overcome this barrier. To add evidence for the feasibility of this approach, we sought to determine PK parameters for fentanyl in children after cardiac surgery using specimens and data generated in the course of clinical care, without collecting additional blood samples. METHODS: We measured fentanyl concentrations in plasma from leftover clinically-obtained specimens in 130 paediatric cardiac surgery patients and successfully generated a PK dataset using drug dosing data extracted from electronic medical records. Using a population PK approach, we estimated PK parameters for this population, assessed model goodness-of-fit and internal model validation, and performed subset data analyses. Through simulation studies, we compared predicted fentanyl concentrations using model-driven weight-adjusted per kg vs. fixed per kg fentanyl dosing. RESULTS: Fentanyl clearance for a 6.4 kg child, the median weight in our cohort, is 5.7 l h(-1) (2.2-9.2 l h(-1) ), similar to values found in prior formal PK studies. Model assessment and subset analyses indicated the model adequately fit the data. Of the covariates studied, only weight significantly impacted fentanyl kinetics, but substantial inter-individual variability remained. In simulation studies, model-driven weight-adjusted per kg fentanyl dosing led to more consistent therapeutic fentanyl concentrations than fixed per kg dosing. CONCLUSIONS: We show here that population PK modelling using sparse remnant samples and electronic medical records data provides a powerful tool for assessment of drug kinetics and generation of individualized dosing regimens.
AIMS: One barrier contributing to the lack of pharmacokinetic (PK) data in paediatric populations is the need for serial sampling. Analysis of clinically obtained specimens and data may overcome this barrier. To add evidence for the feasibility of this approach, we sought to determine PK parameters for fentanyl in children after cardiac surgery using specimens and data generated in the course of clinical care, without collecting additional blood samples. METHODS: We measured fentanyl concentrations in plasma from leftover clinically-obtained specimens in 130 paediatric cardiac surgery patients and successfully generated a PK dataset using drug dosing data extracted from electronic medical records. Using a population PK approach, we estimated PK parameters for this population, assessed model goodness-of-fit and internal model validation, and performed subset data analyses. Through simulation studies, we compared predicted fentanyl concentrations using model-driven weight-adjusted per kg vs. fixed per kg fentanyl dosing. RESULTS:Fentanyl clearance for a 6.4 kg child, the median weight in our cohort, is 5.7 l h(-1) (2.2-9.2 l h(-1) ), similar to values found in prior formal PK studies. Model assessment and subset analyses indicated the model adequately fit the data. Of the covariates studied, only weight significantly impacted fentanyl kinetics, but substantial inter-individual variability remained. In simulation studies, model-driven weight-adjusted per kg fentanyl dosing led to more consistent therapeutic fentanyl concentrations than fixed per kg dosing. CONCLUSIONS: We show here that population PK modelling using sparse remnant samples and electronic medical records data provides a powerful tool for assessment of drug kinetics and generation of individualized dosing regimens.
Authors: D Gonzalez; C Melloni; R Yogev; B B Poindexter; S R Mendley; P Delmore; J E Sullivan; J Autmizguine; A Lewandowski; B Harper; K M Watt; K C Lewis; E V Capparelli; D K Benjamin; M Cohen-Wolkowiez Journal: Clin Pharmacol Ther Date: 2014-06-20 Impact factor: 6.903
Authors: Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker Journal: Clin Pharmacokinet Date: 2018-03 Impact factor: 6.447
Authors: Fanuel T Hagos; Christopher M Horvat; Alicia K Au; Yvette P Conley; Lingjue Li; Samuel M Poloyac; Patrick M Kochanek; Robert S B Clark; Philip E Empey Journal: Clin Pharmacokinet Date: 2019-12 Impact factor: 6.447
Authors: Sara L Van Driest; Matthew D Marshall; Brian Hachey; Cole Beck; Kim Crum; Jill Owen; Andrew H Smith; Prince J Kannankeril; Alison Woodworth; Richard M Caprioli; Leena Choi Journal: Br J Clin Pharmacol Date: 2016-04-15 Impact factor: 4.335
Authors: Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker Journal: Clin Pharmacokinet Date: 2018-02 Impact factor: 6.447
Authors: Dan M Roden; Sara L Van Driest; Quinn S Wells; Jonathan D Mosley; Joshua C Denny; Josh F Peterson Journal: Circ Res Date: 2018-04-27 Impact factor: 17.367
Authors: Sebastiaan C Goulooze; Erwin Ista; Monique van Dijk; Dick Tibboel; Elke H J Krekels; Catherijne A J Knibbe Journal: AAPS J Date: 2021-05-17 Impact factor: 4.009
Authors: Anil R Maharaj; Huali Wu; Kanecia O Zimmerman; David G Speicher; Janice E Sullivan; Kevin Watt; Amira Al-Uzri; Elizabeth H Payne; Jinson Erinjeri; Susan Lin; Barrie Harper; Chiara Melloni; Christoph P Hornik Journal: J Clin Pharmacol Date: 2019-12-08 Impact factor: 2.860
Authors: Leena Choi; Cole Beck; Elizabeth McNeer; Hannah L Weeks; Michael L Williams; Nathan T James; Xinnan Niu; Bassel W Abou-Khalil; Kelly A Birdwell; Dan M Roden; C Michael Stein; Cosmin A Bejan; Joshua C Denny; Sara L Van Driest Journal: Clin Pharmacol Ther Date: 2020-02-11 Impact factor: 6.875